(reported by the Company)
No items found
is a drug delivery company focused on oro-mucosal administration. The Company is publicly listed on the Australian Stock Exchange (ASX: SUD) and headquartered in Perth, Western Australia.
Our business model is based on the development of low-risk pharmaceuticals using novel formulations of existing drugs that are off patent. We re-formulate these drugs to provide patentable products or line extensions for existing franchises.
Our proprietary OroMist® drug delivery platform has broad potential to enhance many classes of existing drugs. We have established a rich pipeline of drug candidates in various stages of development, and we will continue to expand the pipeline through the application of our oro-mucosal technology and also through acquisitions.
|Category:||Health & biotech|
|ASX Listing Code (if applicable):||SUD|
|Year of Commencement:|